RESISTANCE OF HELICOBACTERPYLORI TO THE COMPONENTS OF ERADICATION THERAPY AND WAYS FOR ITS OVERCOMING


A.A. Samsonov (1), D.N. Andreev (1), V.B. Grechushnikov (2), R.A. Aivazova (1)

(1) SBEI HPE "Moscow State Medical Stomatological University n.a. A.I. Evdokimov" of RMPH, Moscow; (2) NSHCI "Central Clinical Hospital № 6" of the JSC Russian Railways, Moscow
The article reflects the current situation of growth of resistance of H. pylori to the main drugs included in the scheme of eradication therapy and, therefore, reduction of the effectiveness of treatment. The authors examine in detail the mechanisms of microbial resistance to antibiotics and provide ways to its overcoming.

About the Autors


A.A. Samsonov – MD, Prof. at the Department of Propedeutics of Internal Diseases and Gastroenterology SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH
D.N. Andreev – Teaching Assistant at the Department of Propedeutics of Internal Diseases and Gastroenterology SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH; e-mail: dna-mit8@mail.ru
V.B. Grechushnikov – PhD in Medical Sciences, doctor of the highest qualification category, Head of the Endoscopic Unit of the Central Clinical Hospital of the Russian Railways № 6; e-mail: virtor_33307@mail.ru; Grechushnikov271960@yandex.ru
R.A. Aivazova - MD, doctoral student at the Department of Geriatric Stomatology, Stomatological Faculty SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH; e-mail: a_reg@mail.ru


Similar Articles


Бионика Медиа